Literature DB >> 22767506

Lipocalin 2, the TNF-like receptor TWEAKR and its ligand TWEAK act downstream of NFAT1 to regulate breast cancer cell invasion.

Benoît Gaudineau1, Marjorie Fougère, Frédéric Guaddachi, Frédéric Lemoine, Pierre de la Grange, Sébastien Jauliac.   

Abstract

NFAT1 is a transcription factor that elicits breast carcinoma cells to become invasive, thus contributing to metastasis. The molecular mechanisms by which NFAT1 operates in this respect are still poorly known. Here, we report that NFAT1 increases lipocalin 2 (LCN2) mRNA and protein expression by binding to specific sites in the LCN2 gene promoter region. We show that the LCN2 protein is required downstream of NFAT1 to increase breast cancer cell invasion. We demonstrate that the NFAT1-LCN2 axis is sufficient to regulate expression of the TNF-like receptor TWEAKR at the RNA level and of its ligand, TWEAK, at the protein level. We show, however, that TWEAKR mediates an anti-invasive effect in breast cancer cells whereas, depending on LCN2 expression, TWEAK has either anti- or pro-invasive capacities. Thus, we identify LCN2 and TWEAKR-TWEAK as crucial downstream effectors of NFAT1 that regulate breast cancer cell motility and invasive capacity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22767506     DOI: 10.1242/jcs.099879

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  11 in total

1.  Low blood levels of sTWEAK are related to locoregional failure in head and neck cancer.

Authors:  Francesc Xavier Avilés-Jurado; Ximena Terra; David Gómez; Joan Carles Flores; Antoni Raventós; Elsa Maymó-Masip; Xavier León; Vicente Serrano-Gonzalvo; Joan Vendrell; Enric Figuerola; Matilde R Chacón
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-05-26       Impact factor: 2.503

2.  Fn14 deficiency protects lupus-prone mice from histological lupus erythematosus-like skin inflammation induced by ultraviolet light.

Authors:  Jessica Doerner; Samantha A Chalmers; Adam Friedman; Chaim Putterman
Journal:  Exp Dermatol       Date:  2016-12       Impact factor: 3.960

Review 3.  The TWEAK/Fn14/CD163 axis-implications for metabolic disease.

Authors:  Wiktoria Ratajczak; Sarah D Atkinson; Catriona Kelly
Journal:  Rev Endocr Metab Disord       Date:  2021-09-20       Impact factor: 9.306

Review 4.  Implication and role of neutrophil gelatinase-associated lipocalin in cancer: lipocalin-2 as a potential novel emerging comprehensive therapeutic target for a variety of cancer types.

Authors:  Sina Rahimi; Amaneh Mohammadi Roushandeh; Ebrahim Ahmadzadeh; Ali Jahanian-Najafabadi; Mehryar Habibi Roudkenar
Journal:  Mol Biol Rep       Date:  2020-01-22       Impact factor: 2.316

5.  Tcf3 promotes cell migration and wound repair through regulation of lipocalin 2.

Authors:  Qi Miao; Amy T Ku; Yudai Nishino; Jeffrey M Howard; Ajay S Rao; Timothy M Shaver; Gloria E Garcia; Diep N Le; Kristen L Karlin; Thomas F Westbrook; Valeria Poli; Hoang Nguyen
Journal:  Nat Commun       Date:  2014-06-09       Impact factor: 14.919

6.  Inhibiting NFAT1 for breast cancer therapy: New insights into the mechanism of action of MDM2 inhibitor JapA.

Authors:  Jiang-Jiang Qin; Wei Wang; Sukesh Voruganti; Hui Wang; Wei-Dong Zhang; Ruiwen Zhang
Journal:  Oncotarget       Date:  2015-10-20

7.  Evaluating the Effect of Cell Culture on Gene Expression in Primary Tissue Samples Using Microfluidic-Based Single Cell Transcriptional Analysis.

Authors:  Michael Januszyk; Robert C Rennert; Michael Sorkin; Zeshaan N Maan; Lisa K Wong; Alexander J Whittam; Arnetha Whitmore; Dominik Duscher; Geoffrey C Gurtner
Journal:  Microarrays (Basel)       Date:  2015-11-04

8.  TCF7L1 promotes skin tumorigenesis independently of β-catenin through induction of LCN2.

Authors:  Amy T Ku; Timothy M Shaver; Ajay S Rao; Jeffrey M Howard; Christine N Rodriguez; Qi Miao; Gloria Garcia; Diep Le; Diane Yang; Malgorzata Borowiak; Daniel N Cohen; Vida Chitsazzadeh; Abdul H Diwan; Kenneth Y Tsai; Hoang Nguyen
Journal:  Elife       Date:  2017-05-03       Impact factor: 8.140

9.  Depleting NFAT1 expression inhibits the ability of invasion and migration of human lung cancer cells.

Authors:  Ji-Fu Liu; Shou-Hua Zhao; Shan-Shan Wu
Journal:  Cancer Cell Int       Date:  2013-05-12       Impact factor: 5.722

10.  DYRK1A activates NFATC1 to increase glioblastoma migration.

Authors:  Heng Liu; Qian Sun; Shuai Chen; Long Chen; Wenming Jia; Juan Zhao; Xiulian Sun
Journal:  Cancer Med       Date:  2021-07-26       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.